Collegium Pharmaceutical Future Growth

How is Collegium Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

46.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:COLL - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	607	130	303	330	5
12/31/2024	598	134	322	316	5
12/31/2023	568	74	255	264	6
9/30/2022	362	-43	93	94	N/A
6/30/2022	314	-35	67	69	N/A
3/31/2022	273	43	56	58	N/A
12/31/2021	277	72	102	104	N/A
9/30/2021	326	104	87	90	N/A
6/30/2021	326	107	102	107	N/A
3/31/2021	321	42	115	121	N/A
12/31/2020	310	27	-280	94	N/A
9/30/2020	308	18	-286	87	N/A
6/30/2020	302	0	-313	59	N/A
3/31/2020	299	-13	-341	30	N/A
12/31/2019	297	-23	21	28	N/A
9/30/2019	296	-11	47	54	N/A
6/30/2019	293	-22	81	90	N/A
3/31/2019	291	-30	123	131	N/A
12/31/2018	280	-39	145	169	N/A
9/30/2018	218	-66	91	114	N/A
6/30/2018	160	-62	39	59	N/A
3/31/2018	90	-70	-34	-14	N/A
12/31/2017	28	-75	-68	-67	N/A
9/30/2017	19	-85	-78	-77	N/A
6/30/2017	7	-98	-85	-84	N/A
3/31/2017	4	-102	-90	-87	N/A
12/31/2016	2	-94	-78	-75	N/A
9/30/2016	0	-76	-64	-61	N/A
6/30/2016	N/A	-59	N/A	-48	N/A

Earnings vs Savings Rate: COLL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: COLL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: COLL is expected to become profitable in the next 3 years.

Revenue vs Market: COLL's revenue (2.3% per year) is forecast to grow slower than the US market (7% per year).

High Growth Revenue: COLL's revenue (2.3% per year) is forecast to grow slower than 20% per year.

Future ROE: Insufficient data to determine if COLL's Return on Equity is forecast to be high in 3 years time